• Clopidogrel Bisulfate Tablets 75mg GMP Medicine

Clopidogrel Bisulfate Tablets 75mg GMP Medicine

Application: Internal Medicine
Usage Mode: For oral administration
Suitable for: Elderly, Adult
State: Solid
Shape: Capsules
Type: Organic Chemicals
Customization:
Gold Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
75mg
Pharmaceutical Technology
Chemical Synthesis
Transport Package
Carton
Specification
75mg 3*10capsules/box
Trademark
Voice-Bio
Origin
China
HS Code
3004909099
Production Capacity
10000000

Product Description

Clopidogrel Bisulfate Tablets
Specification 75mg  3*10capsules/box
Shelf life 3years
Storage Store in a cool and dry place below 25ºC

Therapeutic indications
Prevention of vascular ischaemia associated with secondary atherothrombotic events (MI,
stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.
Acute coronary syndrome
Clopidogrel is indicated in combination with aspirin for patients with:
 Unstable angina or non-ST elevation MI. Clopidogrel is indicated for early and long-term
reduction of atherothrombotic events (myocardial infarction, stroke, vascular death and
refractory ischaemia) whether or not patients undergo cardiac revascularisation (surgical
or PCI, with or without stent).
 ST-segment elevation acute myocardial infarction. In this population, clopidogrel has been
shown to reduce the rate of death from any cause and the rate of a combined endpoint of
death, re-infarction or stroke.
Dose and method of administration
Clopidogrel should be taken once a day with or without food.
Adults
Generally, clopidogrel should be given as a single daily dose of 75 mg.
In patients with acute coronary syndrome:
 unstable angina or non-ST elevation myocardial infarction - clopidogrel treatment should
be initiated with a single 300 mg loading dose and then continued long-term at 75 mg once
a day (with aspirin 75 mg-325 mg daily).
 ST elevation acute myocardial infarction - clopidogrel treatment should be given as a single
daily dose of 75 mg initiated with or without a 300 mg loading dose in combination with
aspirin and with or without thrombolytics.

No dosage adjustment is necessary for either elderly patients or patients with renal impairment

Children and adolescents
Safety and efficacy in subjects below the age of 18 have not been established.
****Follow all directions given to you by your doctor and pharmacist carefully

Packaging & Shipping
Comercial Packing or Customized
Production Time About 30-60days after artwork confirmed


Clopidogrel Bisulfate Tablets 75mg GMP MedicineCertifications
Business License, Manufacturing License, Certificate of Pharmaceutical Products (CoPP), Free Sales Certificate (FSC), and technical documents for registration.
 
Clopidogrel Bisulfate Tablets 75mg GMP Medicine
Since 2015, NINGBO VOICE BIOCHEMIC CO. LTD. is a professional company to offer one-package service for FPP (Finished Pharmaceutical Products ); APIs (Active Pharmaceutical Ingredients); (Pharmaceutical Intermediates ); Veterinary Pharmaceuticals.that meet of Standard GMP and current BP,USP version.
 

Our Service
1.Mixed container, we can mix different items in one container.
2.Free professional and creative artwork design.
3.OEM service.
4.Registration documents supported.
5.Packing as your request, with photo before shipment.


We will spare no efforts to meet your demands!
 please feel free to contact us 
    
       
 

 
Address:   298 West Zhongshan Road, Ningbo, P.R. China 
Attn: Mr. Medic  Ren  







 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Registered Capital
5000000 RMB
Plant Area
101~500 square meters